Back to search

Oxford Biotherapeutics Ltd

04974481

active
Private Limited Company
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Going concern doubt noted in accounts (-10)

Details

SUITE A, SECOND FLOOR, THE SCHRODINGER BUILDING HEATLEY ROAD, OXFORD, OX4 4GE
Incorporated 24/11/2003

Compliance

Last accounts

31/12/2024

group

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 27/05/2026

Due 10/06/2027

On track

Industry

72110
Research and experimental development on biotechnology
72190
Other research and experimental development on natural sciences and engineering
74909
Other professional, scientific and technical activities

Officers

Doctor Christian Rohlff Phd

director · Since 11/12/2003

CHIEF EXECUTIVE OFFICE, DIRECTOR

GERMAN · UNITED KINGDOM · Age 64

Doctor Jean Pierre Bizzari

director · Since 14/12/2016

DIRECTOR

FRENCH,AMERICAN · UNITED STATES · Age 71

Bernd Robert Seizinger

director · Since 14/12/2016

DIRECTOR

GERMAN · UNITED STATES · Age 69

Mr Jason Lee Gould

director · Since 15/12/2020

DIRECTOR

BRITISH · ENGLAND · Age 56

Also on 4 other boards

Persons with Significant Control

Catapult Growth Fund Limited (As Gp For Catapult Growth Fund Limited Partnership)

25–50% shares

Malt House, 13 Narborough Wood Business Park, Enderby, LE19 4XT

Reg: 5929758 · Companies House · Corporate

Notified 24/11/2018

South East Growth Fund Managers Limited

50–75% shares

Wellington House, 31-34 Waterloo Street, Birmingham, M2 5TJ

Reg: 3963896 · Companies House · Corporate

Notified 24/11/2018

Gkf Wealth Management Limited

25–50% votes

Lytchett House, 13 Freeland Park, Wareham Road, Poole, BH16 6FA

Notified 24/11/2018

Former PSCs

Share Nominees Limited

Ceased 24/11/2018

Charges0 outstanding

Charge
satisfied

OXFORD FINANCE LLC AS SECURITY AGENT.

Created 28/08/2019Registered 10/09/2019Satisfied 22/01/2021
Charge
satisfied

OXFORD FINANCE LLC (AS COLLATERAL AGENT)

Created 14/12/2016Registered 21/12/2016Satisfied 22/01/2021
Charge
satisfied

SILICON VALLEY BANK

Created 03/06/2015Registered 09/06/2015Satisfied 30/12/2016
charge
satisfied

BARCLAYS BANK PLC

Created 12/05/2008Registered 16/05/2008Satisfied 23/04/2015
charge
satisfied

OXFORD GLYCOSIENCES (UK) LIMITED

Created 14/06/2005Registered 23/06/2005Satisfied 23/04/2015

CompanyRankvs 12+ SIC 72110 peers
79

Financial strength95th percentile among SIC peers · 24/25
Employees100th percentile among SIC peers · 15/15
LiquidityCurrent ratio 7.27× · 20/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to

Key FinancialsYear ending 31/12/2024

Net Worth

£2.1M

Balance sheet strength

Cash

£4.8M

Cash in the bank

Net Current Assets

£3.2M

Working capital

Current Assets

£9.6M

Current Liabilities

£1.3M

Fixed Assets

£273k

Debtors

£5.0M

Cost of Sales

£554k

Admin Expenses

£17.6M

Profit After Tax

£3.6M

4958396avg. employees-1133287

Tax at Year End(2023)

Corp tax£0

People Costs

Wages & salaries£5.3M

Balance Sheet

Intangible assets£0
Assets less current liabilities£3.5M
Prepared with CCH Software

EstimatesDerived

YearCurrent RatioImplied Profit
20247.27+£532k
20231.81

Derived from filed accounts. Not audited figures.